US blood banks set up new testing procedures to enhance detection of viruses
This article was originally published in Clinica
US blood banks have begun phasing in nucleic acid testing (NAT) that will greatly reduce the chance that viruses such as HIV-1 and hepatitis C will slip into the nation's blood supply. The new tests employ gene amplification technology to search for bits of a virus contained in its genetic material.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.